Page last updated: 2024-08-24

ziprasidone and Autosomal Dominant Juvenile Parkinson Disease

ziprasidone has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baralatei, FT; Lauterbach, EC1
Cansel, N; Herken, H; Ozen, ME; Savas, HA; Yumru, M1

Other Studies

2 other study(ies) available for ziprasidone and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Switching to duloxetine remits ziprasidone - associated urinary incontinence and improves neuropsychiatric behavior in dementia: possible relationship of incontinence to 5HT2 receptor blockade.
    Psychopharmacology bulletin, 2009, Volume: 42, Issue:3

    Topics: Aged, 80 and over; Alzheimer Disease; Dementia, Vascular; Duloxetine Hydrochloride; Humans; Male; Parkinsonian Disorders; Piperazines; Receptors, Serotonin, 5-HT2; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Thiazoles; Thiophenes; Urinary Incontinence

2009
Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2007, Volume: 8, Issue:1

    Topics: Adult; Antipsychotic Agents; Biperiden; Diagnosis, Differential; Diazepam; Drug Therapy, Combination; Humans; Infusions, Intravenous; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Parkinsonian Disorders; Piperazines; Schizophrenia; Thiazoles

2007